Hyaluronic acid Completed Phase 2 Trials for Dry Eye Syndromes Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01135511A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease